Features of cystadenofibroma on magnetic resonance imaging: an update using the O-RADS lexicon and considering diffusion-weighted and perfusion imaging.


Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 13 04 2022
revised: 31 05 2022
accepted: 29 06 2022
pubmed: 8 7 2022
medline: 26 8 2022
entrez: 7 7 2022
Statut: ppublish

Résumé

Cystadenofibroma (CAF) is a rare tumour of the ovary that can be confused with a borderline or malignant lesion due to its morphological characteristics. The study aims to analyse the MRI (magnetic resonance imaging) features of histologically proven ovarian cystadenofibromas according to lexicon-based and O-RADS (Ovarian-Adnexal Reporting and Data System) descriptors, with particular attention to time-intensity curves (TIC) and Diffusion-Weighted sequences (DWI); we also wanted to test the performance of O-RADS MRI risk stratification system in this particular subgroup of patients. We have included all patients who performed MR between October 2019 and December 2021 after an inconclusive trans-vaginal ultrasound. All patients underwent surgery with histological results of CAF. According to the O-RADS lexicon, we reported the morphological characteristics of each lesion and their appearance in the perfusion-weighted imaging (PWI) and DWI sequences. We assessed the risk of malignancy for each lesion through O-RADS MRI score. Twenty-one histologically proven CAF were analysed, of which 20 benign and one borderline with degeneration into adenocarcinoma. We described the typical morphological characteristics of CAF according to lexicon-based and O-RADS descriptors. Analysis of time-intensity curves (TIC) in PWI sequences showed a slow and progressive enhancement of solid tissue (type I curve), configuring an O-RADS score of 2 or 3, except for the only malignant lesion that showed a type II curve and restriction in DWI (O-RADS 4). Our study is the largest comprising PWI and DWI sequences, highlighting their pivotal role. O-RADS score correctly classified the masses as benign or malignant.

Identifiants

pubmed: 35797789
pii: S0720-048X(22)00279-0
doi: 10.1016/j.ejrad.2022.110429
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110429

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Giacomo Avesani (G)

Department of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico "A. Gemelli" IRCCS, Rome, Italy.

Lorenzo Elia (L)

Catholic University of the Sacred Hearth, Rome, Italy.

Andrea Giovanni Anghelone (AG)

Catholic University of the Sacred Hearth, Rome, Italy.

Alessio Perazzolo (A)

Catholic University of the Sacred Hearth, Rome, Italy.

Camilla Panico (C)

Department of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico "A. Gemelli" IRCCS, Rome, Italy.

Valerio Di Paola (V)

Department of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico "A. Gemelli" IRCCS, Rome, Italy. Electronic address: valerio.dipaola@policlinicogemelli.it.

Benedetta Gui (B)

Department of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico "A. Gemelli" IRCCS, Rome, Italy.

Elena Rodolfino (E)

Department of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico "A. Gemelli" IRCCS, Rome, Italy.

Francesca Moro (F)

Department of Woman, Child and Public Health, Fondazione Policlinico "A. Gemelli" IRCCS, Rome, Italy.

Antonia Carla Testa (AC)

Catholic University of the Sacred Hearth, Rome, Italy; Department of Woman, Child and Public Health, Fondazione Policlinico "A. Gemelli" IRCCS, Rome, Italy.

Riccardo Manfredi (R)

Department of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico "A. Gemelli" IRCCS, Rome, Italy; Catholic University of the Sacred Hearth, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH